Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L‐thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer
Santoro, Ana B., Vargens, Daniela D., Barros Filho, Mateus de Camargo, Bulzico, Daniel A., Kowalski, Luiz Paulo, Meirelles, Ricardo M. R., Paula, Daniela P., Neves, Ronaldo R. S., Pessoa, Cencita N., Struchine, Claudio J., Suarez‐Kurtz, Guilherme
Published in British journal of clinical pharmacology (01.11.2014)
Published in British journal of clinical pharmacology (01.11.2014)
Get full text
Journal Article